A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

O Clewe, SG Wicha, CP de Vogel… - Journal of …, 2018 - academic.oup.com
Background Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

O Clewe, S Wicha, C de Vogel… - Journal of …, 2017 - repub.eur.nl
Background Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …

[HTML][HTML] A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

O Clewe, SG Wicha, CP de Vogel… - Journal of …, 2018 - ncbi.nlm.nih.gov
Background Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …

[PDF][PDF] A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

O Clewe, SG Wicha, CP de Vogel… - Journal of …, 2018 - academic.oup.com
Background Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …

[PDF][PDF] A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

O Clewe, SG Wicha, CP de Vogel… - J Antimicrob …, 2018 - core.ac.uk
Background: Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.

O Clewe, SG Wicha, CP de Vogel… - The Journal of …, 2018 - europepmc.org
Background: Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.

O Clewe, SG Wicha, CP Vogel, JEM Steenwinkel… - 2018 - cabidigitallibrary.org
Background: Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

O Clewe, SG Wicha, CP de Vogel… - The Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

O Clewe, SG Wicha, CP de Vogel… - Journal of …, 2018 - diva-portal.org
Background: Identification of pharmacodynamic interactions is not reasonable to carry out in
a clinical setting for many reasons. The aim of this work was to develop a model-informed …